GoodFlip, the digital therapeutics platform of Bengaluru‑based TatvaCare, issued a press release on 19 November 2026 announcing that actor and endurance athlete Milind Soman, aged 61, has been appointed as its brand ambassador. The partnership is positioned to reinforce GoodFlip’s emphasis on consistency in metabolic health, aligning Soman’s personal philosophy of simple, daily habits with the company’s EM3 framework – Eat, Move, Mind and Measure.
Soman, known for completing an Ironman in 2015 and for long barefoot runs, said, “I eat simple food, move every day, sleep well and challenge myself regularly,” and added that GoodFlip’s focus on simple habits, a clear framework, and doctor support attracted him. TatvaCare CEO Manoj Balaji echoed the message, stating that metabolic health is about consistent lifestyle choices rather than a target weight, and that GoodFlip aims to make that consistency easier for every Indian.
The release highlighted India’s metabolic health crisis, citing ICMR‑INDIAB 2023 data that more than 100 million Indians have diabetes and another 136 million have pre‑diabetes, with rising rates of fatty liver, hypertension and PCOS. GoodFlip’s approach treats these conditions as a single metabolic system, using doctor‑led programmes built around EM3. Each member receives support from a care team of doctors, nutritionists, and habit coaches, and progress is measured through the MetScore, which aggregates glycaemic control, body‑fat percentage, muscle mass and liver health, with HbA1c remaining a key indicator.
Clinical evidence was cited: the GLIDE study, conducted on Indian patients in the diabetes programme, recorded an average 11.9 % reduction in HbA1c over twelve weeks with adherence above 80 %; the RESET study, published in the World Journal of Hepatology, applied the same methodology to fatty‑liver patients. To date, GoodFlip has impacted more than 50 000 lives.
The platform’s technology stack includes the AI‑driven health assistant KAIRA, a body‑composition analyser (BCA), and a continuous glucose monitor (CGM). An upcoming hardware addition, the Arc ring, will track sleep, energy and stress continuously, feeding data into KAIRA and the MetScore. The ring is designed specifically for Indian bodies and is slated for launch in early 2027.
TatvaCare’s broader reach is noted: its products, including TatvaPractice and GoodFlip, are used by over 10 000 doctors across more than 200 cities, have generated over 2.5 million digital prescriptions, and support the same 50 000+ GoodFlip users. The company is ABDM certified. The press release was distributed through NewsVoir under a partnership arrangement, with PTI stating no editorial responsibility.